Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Streck CD-Chex™ Plus Immunophenotyping Control
SDP

Catalog No. p-108854
Click to view available options
Level:
CD4 Low
CD4 Low, Normal
Normal
Quantity:
2 x 3 mL
4 x 3 mL
5 x 3 mL
10 x 3 mL
Format:
Cap-pierceable Plastic Vial

CD-Chex Plus is a positive procedural control for T-lymphocyte, B-lymphocyte and NK cell enumeration and features two clinically relevant levels of CD4+ cells, a normal level of CD34+ cells and several other parameters for use as leukemia and lymphoma quality controls.

  • Assayed for 30 parameters, including T-lymphocytes, B-lymphocytes and NK cells.
  • Contains a CD34+ population and is available in two clinically relevant CD4+ levels.
  • Compatible with BD Biosciences and Beckman Coulter flow cytometry systems.
  • 30-day open-vial stability, 90-day closed-vial stability.
  • Manufacturer established assay ranges – no need to verify range per CAP requirements.
  • Access to STATS™, Streck’s free interlaboratory quality control program for peer group data comparison.

Specifications

Certifications/Compliance CE
Content And Storage 2°C to 10°C
Format Cap-pierceable Plastic Vial
For Use With (Equipment) Beckman Coulter™ flow cytometry system
Type CD-Chex™ plus Immunophenotyping Control
Intended Use Immunophenotyping including RBC lysis, Antibody staining, instrument performance and operator technique
Level Normal
Quantity 2 x 3 mL
Source Human Peripheral Blood Leukocytes and Erythrocytes
Stability 3 Months
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.